Series C Funded Startups in China
Across the 22 most recent Series C rounds in China, the largest disclosed amount is GRIT Biotechnology’s $84M (2025-10-19).
Across the 22 most recent Series C rounds in China, the largest disclosed amount is GRIT Biotechnology’s $84M (2025-10-19). That figure sits well above the next-largest disclosed rounds—Kind Pharmaceutical and ATAPEX are both $56M (2025-11-13 and 2025-11-08), followed by Full-Life Technologies at $50M (2025-10-05). A second pattern shows clustering by time: 7 of the 22 rounds fall between 2025-11-20 and 2025-11-29, with multiple hardware/manufacturing-linked companies also appearing during that same late-November window (e.g., Booster tech $28M on 2025-11-20; Link Touch $14M on 2025-11-20; Zongwei Automation on 2025-09-08).
Sector-wise, biotech/pharma is repeatedly represented (Healsun Biopharm on 2025-11-21; Kind Pharmaceutical on 2025-11-13; Full-Life Technologies on 2025-10-05; GRIT Biotechnology on 2025-10-19), while disclosed amounts are sparse: 13 of 22 entries are “undisclosed,” and only a minority of rounds show dollar values (e.g., Booster tech $28M on 2025-11-20; Digitgate Communication Technology $14M on 2025-10-01). The date range for the displayed set runs from 2025-09-08 through 2025-11-29, with most entries concentrated in September and November and none earlier than 2025-09-08.
Most recent rounds
22 shownRelated listings
Frequently asked
Which disclosed Series C round is the size outlier in this China list?
GRIT Biotechnology’s $84M (2025-10-19) is the clear disclosed outlier. The next-largest disclosed amounts are $56M for Kind Pharmaceutical (2025-11-13) and ATAPEX (2025-11-08), with Full-Life Technologies at $50M (2025-10-05) and no other disclosed entry above that.
How concentrated are these rounds in late November, and does any disclosed-heavy cluster show up there?
Seven of the 22 rounds close between 2025-11-20 and 2025-11-29, including Booster tech’s $28M (2025-11-20) and Link Touch’s $14M (2025-11-20). In that same late-November slice, multiple others are undisclosed (e.g., isheji.com on 2025-11-29; Aerofugia on 2025-11-27).
Are biotech and pharma companies over-represented compared with other categories in this set?
Biotech/pharma appears repeatedly: Healsun Biopharm (2025-11-21, undisclosed), Kind Pharmaceutical (2025-11-13, $56M), Full-Life Technologies (2025-10-05, $50M), and GRIT Biotechnology (2025-10-19, $84M). This creates a notably denser cluster than single-appearance verticals like materials (Kingwills New Materials, 2025-09-21, undisclosed).
What fraction of rounds have disclosed amounts, and what does that imply for comparing sizes?
Only 9 of 22 entries list a dollar amount; 13 of 22 are “undisclosed.” As a result, size comparisons rely on a limited subset—e.g., disclosed entries range from $14M (Link Touch on 2025-11-20 and Digitgate Communication Technology on 2025-10-01) up to $84M (GRIT Biotechnology on 2025-10-19).
Are there geographic concentration signals across the cities shown (e.g., Shanghai vs Shenzhen vs Hangzhou)?
Shanghai is the most frequent city in the displayed set, appearing for Sijie Microelectronics (2025-11-02), GRIT Biotechnology (2025-10-19), Full-Life Technologies (2025-10-05), and Kingwills New Materials (2025-09-21). Shenzhen also recurs (Link Touch on 2025-11-20, NetForward on 2025-09-12, HiStarlink on 2025-09-24), but with fewer total entries than Shanghai.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.